JMP Securities Starts Transcept Pharmaceuticals (TSPT) at Market Outperform

JMP Securities initiates coverage on Transcept Pharmaceuticals (NASDAQ: TSPT) with a Market Outperform. PT $15.00.

For an analyst ratings summary and ratings history on Transcept Pharmaceuticals click here. For more ratings news on Transcept Pharmaceuticals click here.

Shares of Transcept Pharmaceuticals closed at $8.15 yesterday, with a 52 week range of $2.58-$11.88.

---

Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• UPDATE: Capstone Starts Facebook (FB) at Hold as Premium Multiple Not Justified
• Update - William Blair Initiates Coverage on Acquity Group (AQ) with an Outperform; Solid Performance with Secular Tailwinds
• UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong

Create E-mail Alert Related Categories

New Coverage

Related Entities

JMP Securities

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter